NEW YORK, May 21, 2024 /PRNewswire/ — Temple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer’s disease. This project is in collaboration with a highly respected Clinical Research Organization…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.